Holen Sie sich die Stockscreener-App
23.31
4.04%
0.905
Schlusskurs vom Vortag:
$22.41
Offen:
$22.49
24-Stunden-Volumen:
54,316
Relative Volume:
1.54
Marktkapitalisierung:
$41.66M
Einnahmen:
$24.05M
Nettoeinkommen (Verlust:
$-363.00K
KGV:
-79.04
EPS:
-0.2949
Netto-Cashflow:
$359.00K
1W Leistung:
+3.83%
1M Leistung:
-2.06%
6M Leistung:
-1.89%
1J Leistung:
+107.38%
1-Tages-Spanne:
$22.00
$23.71
1-Wochen-Bereich:
$22.00
$23.99
52-Wochen-Spanne:
$10.60
$33.63
Precipio Inc Stock (PRPO) Company Profile
Firmenname
Precipio Inc
Sektor
Branche
Telefon
203 787 7888
Adresse
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
23.31 | 40.05M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Precipio Inc Aktie (PRPO) Neueste Nachrichten
Price to sales forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to revenue forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Precipio, Inc. Actuals & Estimates (NASDAQ:PRPO) - TradingView
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Lack of quorum may force costly delay of Precipio shareholder meeting - Stock Titan
Cancer diagnostics firm Precipio heads to Vegas for Planet MicroCap 2026 - Stock Titan
Avoiding Lag: Real-Time Signals in (PRPO) Movement - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher Amid Consolidation Near ResistanceShort Setup Alerts - newsline.com
Precipio Inc. (PRPO) Edges Higher as Stock Nears ResistanceSell Signal Alerts - newsline.com
Precipio (PRPO) Q1 2026 Earnings Call Transcript - AOL.com
Precipio Q2 2025 Earnings: Positive EPS Marks a Milestone Despite Market ReactionMargin Compression Risk - newsline.com
Precipio (PRPO) Q4 2025 Earnings Transcript - AOL.com
PRPO Q2 2025 Earnings: Profitable Quarter Achieved Despite Revenue UncertaintyRevenue Breakdown Analysis - newsline.com
Discipline and Rules-Based Execution in PRPO Response - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Marks a Turning Point for Diagnostic PlatformEarnings Growth Forecast - The Legal Advocate
Precipio director Richard Sandberg sells $22,517 in common stock By Investing.com - Investing.com Nigeria
Precipio director Richard Sandberg sells $22,517 in common stock - Investing.com
Precipio (PRPO) director-linked entity reports 900-share open-market sale - Stock Titan
Number of shareholders of Precipio, Inc. – GETTEX:TGK - TradingView
Precipio Q2 2025 Earnings: Company Reports Positive EPS of $0.05; Stock Declines 3.09%Growth Acceleration Report - thelegaladvocate.com
Precipio Inc. (PRPO) Q2 2025 Earnings: Unexpected Profitability Amid Revenue ChallengesEPS Growth Report - newsline.com
Precipio Stock Slides Before Holiday — Why Tuesday’s Open Matters - Bez Kabli
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth - TradingView
Precipio (PRPO) director Sandberg reports 3,134-share net stock sale in Form 4 - Stock Titan
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges By GuruFocus - Investing.com Canada
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Gr - GuruFocus
Earnings call transcript: Precipio Inc Q1 2026 sees revenue growth amid margin pressures - Investing.com Nigeria
Finanzdaten der Precipio Inc-Aktie (PRPO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precipio Inc-Aktie (PRPO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
24.89 |
2,034 |
50,632 |
8,142 |
| SANDBERG RICHARD A | Director |
May 19 '26 |
Sale |
24.42 |
600 |
14,652 |
4,400 |
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
25.00 |
500 |
12,500 |
3,900 |
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):